Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carles Pericay

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Cancers|August 7, 2021
Preoperative Diagnostic Uncertainty in T2-T3 Rectal Adenomas and T1-T2 Adenocarcinomas and a Therapeutic Dilemma: Transanal Endoscopic Surgery, or Total Mesorectal Excision?Xavier Serra-Aracil, Noemi Montes, Laura Mora-Lopez, et al.
World Journal of Surgery|March 14, 2008
Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgeryXavier Serra-Aracil, Helena Vallverdú, Jordi Bombardó-Junca, et al.
Cancers|October 6, 2020
Target Enrichment Enables the Discovery of lncRNAs with Somatic Mutations or Altered Expression in Paraffin-Embedded Colorectal Cancer SamplesSusana Iraola-Guzmán, Anna Brunet-Vega, Cinta Pegueroles, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 25, 2021
T1 Rectal Adenocarcinoma: a Different Way to Measure Tumoral Invasion Based on the Healthy Residual Submucosa with Its Prognosis and Therapeutic ImplicationsAlex Casalots, Xavier Serra-Aracil, Laura Mora-Lopez, et al.
Journal of Pharmaceutical Policy and Practice|December 19, 2025
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysisCandela Calle, Elena Elez, José Luis Manzano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2010
Haemolytic uraemic syndrome associated with gemcitabineIrene Moya-Horno, Rosa Querol Niñerola, Teresa Bonfill Abella, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2015
Current controversies in the management of metastatic colorectal cancerRuth Vera, Vicente Alonso, Javier Gállego, et al.
Scientific Reports|December 21, 2017
Plasma sample based analysis of gastric cancer progression using targeted metabolomicsSergio Lario, Maria José Ramírez-Lázaro, Daniel Sanjuan-Herráez, et al.
Oncology Research|April 26, 2014
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancerAlberto Muñoz, Carles Pericay, Carlos García-Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)Jaume Capdevila, Ma Auxiliadora Gómez, Mónica Guillot, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Cancers|August 7, 2021
Preoperative Diagnostic Uncertainty in T2-T3 Rectal Adenomas and T1-T2 Adenocarcinomas and a Therapeutic Dilemma: Transanal Endoscopic Surgery, or Total Mesorectal Excision?Xavier Serra-Aracil, Noemi Montes, Laura Mora-Lopez, et al.
World Journal of Surgery|March 14, 2008
Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgeryXavier Serra-Aracil, Helena Vallverdú, Jordi Bombardó-Junca, et al.
Cancers|October 6, 2020
Target Enrichment Enables the Discovery of lncRNAs with Somatic Mutations or Altered Expression in Paraffin-Embedded Colorectal Cancer SamplesSusana Iraola-Guzmán, Anna Brunet-Vega, Cinta Pegueroles, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 25, 2021
T1 Rectal Adenocarcinoma: a Different Way to Measure Tumoral Invasion Based on the Healthy Residual Submucosa with Its Prognosis and Therapeutic ImplicationsAlex Casalots, Xavier Serra-Aracil, Laura Mora-Lopez, et al.
Journal of Pharmaceutical Policy and Practice|December 19, 2025
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysisCandela Calle, Elena Elez, José Luis Manzano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2010
Haemolytic uraemic syndrome associated with gemcitabineIrene Moya-Horno, Rosa Querol Niñerola, Teresa Bonfill Abella, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2015
Current controversies in the management of metastatic colorectal cancerRuth Vera, Vicente Alonso, Javier Gállego, et al.
Scientific Reports|December 21, 2017
Plasma sample based analysis of gastric cancer progression using targeted metabolomicsSergio Lario, Maria José Ramírez-Lázaro, Daniel Sanjuan-Herráez, et al.
Oncology Research|April 26, 2014
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancerAlberto Muñoz, Carles Pericay, Carlos García-Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)Jaume Capdevila, Ma Auxiliadora Gómez, Mónica Guillot, et al.
Pageof 7